Market Closed

JNJ
Johnson & Johnson
$ 267.28
0.06%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a few seconds ago

Johnson & Johnson News

Latest Johnson & Johnson Stock News & JNJ Headlines

Johnson & Johnson's RYBREVANT® (amivantamab-vmjw) plus chemotherapy delivers longest reported median overall survival in EGFR exon 20 insertion mutation-positive lung cancer
3 days ago | prnewswire.com
J&J Is In Talks to Sell Its Hips-and-Knees Business to Apollo for $20 Billion
4 days ago | wsj.com
2 Outstanding Dividend Stocks to Buy and Hold for 10 Years
5 days ago | fool.com
Johnson & Johnson (JNJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know
8 days ago | zacks.com
Johnson & Johnson spotlights new neuropsychiatry data across bipolar mania, depression and schizophrenia at Psych Congress 2026
8 days ago | prnewswire.com
Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts
15 days ago | zacks.com
Johnson & Johnson (JNJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know
21 days ago | zacks.com
5 Blue-Chip Dividend Stocks to Buy Before August Ends
21 days ago | 247wallst.com
Johnson & Johnson (JNJ) Registers a Bigger Fall Than the Market: Important Facts to Note
a month ago | zacks.com
5 Dependable Dividend Stocks to Buy in August
a month ago | 247wallst.com
Load More

Download App

Keep track of your holdings and explore over 47,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

JNJ
Johnson & Johnson
$ 267.28
0.06%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a few seconds ago